Atabak Ghanizadeh Tabriz is a research scientist at University of Greenwich. His research focuses on exploration of various 3D printing technologies (FDM, DOD SLA and SLS) within biomedical and pharmaceutical fields. His main area of research interest is to explore 3D printing of Solid dosage forms towards personalized medication as well as extracting the full potential of 3D printing in pharmaceutical industry.
Atabak has worked under European and internarial projects funded by Interreg, Celgene and Bristol Meyer Squib.
Atabak has published more than 10 full papers, and 2 book chapters on 3D printing application in biomedical and pharmaceutical files.
Atabak Ghanizadeh Tabriz is a research scientist at University of Greenwich. His research focuses on exploration of various 3D printing technologies (FDM, DOD SLA and SLS) within biomedical and pharmaceutical fields. His main area of research interest is to explore 3D printing of Solid dosage forms towards personalized medication as well as extracting the full potential of 3D printing in pharmaceutical industry.
Atabak has worked under European and internarial projects funded by Interreg, Celgene and Bristol Meyer Squib.
Atabak has published more than 10 full papers, and 2 book chapters on 3D printing application in biomedical and pharmaceutical files.